⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Coherus BioSciences, Inc.

$1.01
+0.01 (+0.50%)

Volume:

673.997K ($674.38K)

Market Capitalization:

$156.05M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Coherus BioSciences Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$1.01
Close$1.01
Low$1.01
Low Change0.00 (0.00%)
High$1.01
High Change+0.00 (+0.00%)
Range$0.00
Volume38.278K
Dollar Volume$38.66K

Regular Trading Hours

-0.01(-0.99%)
Open$1.01
Close$1.00
Low$0.98
Low Change-0.03 (-2.97%)
High$1.02
High Change+0.01 (+0.99%)
Range$0.04
Volume635.719K
Dollar Volume$635.72K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.04%)
Open$1.01
Close$1.01
Low$1.01
Low Change0.00 (0.00%)
High$1.01
High Change+0.00 (+0.04%)
Range$0.00
Volume68.251K
Dollar Volume$68.96K

Regular Trading Hours Yesterday

-0.03(-2.43%)
Open$1.03
Close$1.01
Low$0.99
Low Change-0.04 (-4.07%)
High$1.04
High Change+0.01 (+0.78%)
Range$0.05
Volume561.756K
Dollar Volume$564.56K

Premarket Yesterday

*No Trades in Segment

Coherus BioSciences Top Trades

Coherus BioSciences's top trade so far today returned +3.06%, while the top short trade returned -2.97%.

Coherus BioSciences Moving Averages

5 Day Moving Average (SMA5)$1.02
10 Day Moving Average (SMA10)$1.02
20 Day Moving Average (SMA20)$1.06
50 Day Moving Average (SMA50)$1.22
100 Day Moving Average (SMA100)$1.32
200 Day Moving Average (SMA200)$1.54

Coherus BioSciences Statistics

Average Volume (30 Days)1.38M
P/E Ratio (Current)-1.24
EPS (Current)-$0.86
Dividend Yield0.00%
Free Cash Flow-$664.71M
Cash Ratio1.10
Current Ratio1.77
Quick Ratio1.70
Debt to Equity0.61
Enterprise Value$119.64M
EV to EBITDA-0.77
EV to Sales2.35
Price to Book2.72
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales3.25
Return on Assets-0.69%
Return on Equity-2.17%

Coherus BioSciences Stock Splits

There have been no stock splits for Coherus BioSciences (CHRS).

Coherus BioSciences Dividends

There have been no dividends for Coherus BioSciences (CHRS).